Leverkusen, Germany
NgenLab Germany GmbH is developing the next generation of animal fertility control through the recombinant protein GnRX G/Q, a novel immunological alternative to chemical, hormonal and surgical castration, built for higher animal welfare and global scalability.
Jülich, Germany
Transforming orthopedic surgery through creating ‘in-bone micro-pharmacies’.
Amsterdam, Netherlands
Allergios is developing an AI-powered microfluidic platform for functional allergy diagnostics.
Our goal is to replace risky oral provocation tests (e.g. DBPCFC) with an automated blood test that analyzes individual cellular immune responses to allergens. The platform integrates digital holography and cellular immunoassays, targeting the fast-growing market of clinical allergy diagnostics and research.
Bern, Switzerland
Babylat helps preterm newborns grow faster and safer during their most vulnerable first weeks of life—using 100% human milk-based fortifiers made on-site from their own mother’s or donor milk.
